Neonatal jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1 (Control): The neonate with jaundice and mother will receive placebo. The neonate with jaundice will receive placebo drops per day is similar to the number of coto
Sponsors
Vice chancellor for research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 14 Days
Inclusion criteria
Inclusion criteria: All term neonate who present with jaundice, whose weights are 2500 to 4000 gr and who are feeding with breast milk The neonate 1 to 14 days old
Exclusion criteria
Exclusion criteria: blood incompatibility; Rh incompatibility; Fauvism; immaturity; need for blood transfusions; infection; hemolysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Baby serum total bilirubin. Timepoint: Every 24 hours for 5 days. Method of measurement: Laboratory test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospitalisation days. Timepoint: At the time of discharge. Method of measurement: From the time of admission to discharge.;Added at 2017-06-11: The incidence of complications arising from the use of Cotoneaster. Timepoint: Added at 2017-06-11: Every 24 hours for 5 days. Method of measurement: Added at 2017-06-11: Observation and complete check list.;Added at 2017-06-11: Evaluation of side effects in case of Cotoneaster. Timepoint: Added at 2017-06-11: Every 24 hours for 5 days. Method of measurement: Added at 2017-06-11: Observation and complete check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Azadbakht
Fharmacy Department, Mazandaran University of Medical Sciences
Outcome results
None listed